Difference between revisions of "WSI24-186-Case-3"

From MGH Learn Pathology
(Creating page)
 
(Added status template)
 
Line 30: Line 30:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=9cbf7d52-6b7d-48ec-b0a3-c1fc38d47008
 
|identifier=9cbf7d52-6b7d-48ec-b0a3-c1fc38d47008
Line 40: Line 39:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=8068c126-9c44-4dff-a42b-0f8655dfdad9
 
|identifier=8068c126-9c44-4dff-a42b-0f8655dfdad9
Line 50: Line 48:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=e0bbcb62-addf-4fe0-8e39-8c14cdaef352
 
|identifier=e0bbcb62-addf-4fe0-8e39-8c14cdaef352
Line 60: Line 57:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=a20af581-a990-48db-9f8f-6331a3fe36b4
 
|identifier=a20af581-a990-48db-9f8f-6331a3fe36b4
Line 70: Line 66:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=3838750a-fa0b-4ae2-b64d-d6feed6e1b72
 
|identifier=3838750a-fa0b-4ae2-b64d-d6feed6e1b72
Line 80: Line 75:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=a0e52997-ae10-4d1f-a442-6606e91a235b
 
|identifier=a0e52997-ae10-4d1f-a442-6606e91a235b
Line 90: Line 84:
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 
}}
 
}}
 
 
{{Media
 
{{Media
 
|identifier=cdfb0cc9-a150-4c12-839c-97c1c154024c
 
|identifier=cdfb0cc9-a150-4c12-839c-97c1c154024c
Line 99: Line 92:
 
|reasonCode=H&E
 
|reasonCode=H&E
 
|basedOn=WSI24-186-Case-3
 
|basedOn=WSI24-186-Case-3
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Cep32
 +
|authoredOn=2024-08-25 20:31:42.035839+00:00
 
}}
 
}}

Latest revision as of 16:35, August 30, 2024

WSI24-186-Case-3
N/A
HPV-associated endocervical adenocarcinoma with ovarian and endometrial spread
September 5, 2024 12:00:00 PM